Mike Jerstad, a Partner at PrairieGold Venture Partners, invests in early-stage companies (pre-seed to Series B). See sector focus and contact routes.
Mike Jerstad, a Partner at PrairieGold Venture Partners, invests in early-stage companies (pre-seed to Series B) primarily in the Midwest, focusing on sectors like life sciences, greentech, information technology, and agricultural biotechnology. His firm typically deploys $0.25 million to $2 million per deal, often leading Series A and B rounds to secure meaningful ownership and active board involvement. Jerstad serves on the boards of notable portfolio companies including Virtual Incision (advanced surgical robotics), Lineagen (diagnostics), Chronix Biomedical (blood tests for chronic illness), and Orasi Medical (drug trial software). His distinctive thesis centers on backing revolutionary solutions for global challenges, such as early cancer detection, renewable energy, and advanced surgical technologies.
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Sioux Falls.
Investors like Mike Jerstad · Full investor directory · Investor access · Company funding database